DIA

Ready, Set, Go! We are excited to introduce the DIA Europe 2025 Advent Calendar, starting 1 December. Uncover exclusive rewards and opportunities each day to enhance your conference experience. Let’s bring on the joyous celebrations together with hashtag #DIAEurope2025! How to participate: 1.      Visit our website daily. 2.      Open the Advent Calendar door. 3.      Redeem your reward or participate in the challenge. Play now: https://bit.ly/41dvCZr Note: All individuals aged at least 18 and working/residing in Switzerland are eligible to participate. #LifeSciences #Countdown #AdventCalendar #ExclusiveRewards

The 2024 DIA Middle East & North Africa (MENA) Conference successfully concluded last week in Cairo, bringing together over 250 participants from across the region and beyond. 🌍👏This achievement would not have been possible without the contributions of our distinguished speakers, engaged attendees, dedicated programme committee members, and DIA members.    In partnership with the Egyptian Drug Authority (EDA), this two-day conference provided an invaluable platform to address opportunities and challenges within the MENA pharmaceutical landscape. 🌟 Discussions covered a wide range of topics, including regional regulatory developments, digital transformation, reliance, clinical trials, and more.    During the Opening Ceremony and Gala Dinner at the historic Manial Palace (Prince Mohamed Ali Palace), we were proud to honor the two winners of the DIA 2025 Regional Inspire Award for Excellence in Service: 🏆 Catherine Al Ashram, 🏆 Shahinaz Badr Another key highlight was the MENA Pharmacovigilance Workshop, which explored the region’s evolving pharmacovigilance landscape, including regulatory updates, orphan drug advancements, AI applications, and healthcare challenges, with expert-led discussions.    Once again, thank you 🎉 and stay tuned for more exciting updates from DIA! #DIAMENA2024 #DIA #EDA #RegulatoryInnovation #Pharmacovigilance #Collaboration A special thanks to: DIA MENA Conference Programme Committee: Amira Younes, Anna L., Catherine Al Ashram, Dina Fathy, Fadilla Lakkis, Imane Hattami, Inas Hujeiri Chehimi, May Shawky, Yameng (Melly) Lin, Nevena Miletic, Niveen Osman, Sara Torgal. EDA Programme Advisors: Asmaa Fouad, Passant Hani, Sondos Mohamed. Local Network Chairs: Abdulrahim Alyahya, Ali Al Shibly Murad, Amina Fazila Laras, Dorra IDIR, Fadela Tazi Saoud Benjelloun, Heba Nabil, Ibrahim Nassar, Mounay Khafaja, Nadia Zalloum. DIA MENA Pharmacovigilance Workshop Programme Committee: Mohammed Fouda, Shahinaz Badr, Raghda Mohamed, Cláudia Ferreira. Our dedicated team: Sara Torgal, Cláudia Ferreira, Ania Mitan, Sonia E. Lo Dolce (Martinez), Marwan Fathallah, 𝐎𝐦𝐧𝐞𝐲𝐚 𝐃𝐚𝐫𝐰𝐢𝐬𝐡, ICOM.

This Giving Season, Donate to DIA Giving Tuesday is fast approaching. Please consider making a donation to DIA. By working together, we facilitate disruptive innovation and advance emerging technologies, for affordable, safe, accessible healthcare solutions. Your donation makes a difference. Donate today! https://ow.ly/nUwR50Ui3E3 #donateDIA #DIAgiving

Time is running out to take advantage of group registration discounts for DIA Europe 2025. Join global leaders and experts shaping the future of healthcare. Hear from one of our Programme Committee members, Momir Radulović, Executive Director of the Slovenian Medicines and Medical Devices Agency (JAZMP), on why this conference is an essential event for advancing knowledge and collaboration in our field. Ensure your team is part of the conversation — group rates are ending on 13 December. Visit our website to learn more and register: https://bit.ly/4aN1NA1. #DIAEurope2025 #LifeSciences #Conference #ProfessionalDevelopment

Regulatory Affairs Professionals Society (RAPS) and DIA are counting down to 28-29 January when we will gather in Brussels, Belgium. We are excited to meet up with global regulators, health authorities, notified bodies and industry partners. Here are just some of the topics to be discussed in Brussels this January: ✳️ Article 117 of the MDR - Where are we now? ✳️ Rule 14 of the MDR - How have changes been managed? ✳️ Rule 21 of the MDR - Aspects of the Consultation ✳️ New EU General Pharmaceutical Legislation: How will it influence Combination Products and Diagnostics? ✳️ Variations on Combination Products - Updates and the latest EMA guidance ✳️ Updates on COMBINE for Combination Products and Diagnostics View more topics and get registered today: https://bit.ly/3YQak2c.

Don’t miss the opportunity to connect with peers and experts, and stay informed on the critical issues shaping the future of healthcare with our upcoming events!📆 Global Pharmacovigilance and Risk Management Strategies Conference https://ow.ly/LYLI50UgZJG January 27-29 | Baltimore, MD Regulatory Submissions, Information, and Document Management Forum https://ow.ly/FbEX50UgZJF February 3-5 | North Bethesda, MD Advertising and Promotion Regulatory Affairs Conference https://ow.ly/gqpj50UgZJH February 24-25 | Bethesda, MD Medical Affairs and Scientific Communications Forum https://ow.ly/kFlf50UgZJJ March 10-12 | Boston, MA Global Labeling Conference https://ow.ly/9mmo50UgZJK April 7-8, 2025 | Arlington, VA

Under the Auspices of the Egyptian Drug Authority Launch of the Middle East and North Africa Pharmaceutical Information Association Conference Professor Dr. Aiman El-Khatib, Vice President of the Egyptian Drug Authority, participated in the opening of the Middle East and North Africa Pharmaceutical Information Association (DIA) Conference, hosted by the Arab Republic of Egypt from November 26 to 27, 2024. In his opening remarks, Dr. Aiman El-Khatib extended a warm welcome to all participants and participating organizations at this year's conference. He expressed the Egyptian Drug Authority's pride in hosting this important regional event, which brings together a select group of pharmaceutical industry leaders, officials from regional and international regulatory authorities, and a distinguished group of academics working in various fields of pharmaceutical research. The Vice President of the EDA emphasized the Egyptian Drug Authority's keenness to promote innovation and develop regulatory systems to ensure the provision of safe and effective medicines for all patients, noting the EDA’s commitment to enhancing regional and international cooperation to achieve regulatory integration and harmony. The conference aims to create an effective environment that allows all stakeholders to share the challenges facing the future of the pharmaceutical industry, agree on realistic scenarios, and discuss the best ways to move forward and work together to find innovative solutions. The conference derives its strength from bringing together a broad representation of stakeholders involved in the drug development lifecycle, starting with health authorities, industry leaders, academics, and extending to patient representatives. The conference focuses on a range of important topics, including regional regulatory developments, regulatory strategies, regulatory integration and harmony, digital transformation, pharmacovigilance, and innovation. The conference reflects the ongoing efforts of the Egyptian Drug Authority to enhance Egypt's position as a regional center for innovation in the pharmaceutical industry and to support the development of health systems to improve health services at both the national and regional levels. This comes within the framework of the EDA’s keenness to participate in and host international forums, and to enhance cooperation in the field of pharmaceuticals, which positively impacts the growth of the national economy and encourages pharmaceutical investment, in accordance with the Egyptian political vision. #EgyptianDrugAuthority #EgyptianDrugAuthorityMediaCenter #EgyptianPharmaceuticals

Explore the agenda for the 2024 #RegulatoryPolicyForum, a collaboration between Regulatory Affairs Professionals Society (RAPS) and DIA next week. Plus, speakers just announced. Join us to hear from experts at EMA, EFPIA, and more: https://bit.ly/3YQak2c.

Elevate Your Presence at #DIAEurope2025! DIA Europe 2025 is where leaders in the life sciences field come together to exchange knowledge, shape policy, and advance innovation. As a sponsor or exhibitor, you will have the unique opportunity to connect with influential decision-makers and establish your organisation as a key player in this important field. Reasons to participate: ◾ Build strategic connections with Regulatory Agencies, Industry, HTAs, Payers, Academia, and Patient Advocacy Groups. ◾ Access forward-looking insights through 100+ expertly curated sessions. ◾ Contribute directly to high-level discussions with leading bodies such as EMA, FDA, WHO, and the European Commission. ◾ Strengthen your brand’s presence with sponsorship opportunities designed to maximise visibility and impact. Take the next step to make your mark in healthcare innovation. ◾ View our Sponsorship & Exhibition Prospectus: https://bit.ly/3NMz98M. ◾ Contact us at diaeurope@mci-group.com to learn more. #DIAEurope2025 #LifeSciences #Conference #Exhibition #Sponsoring

Last chance to register! Our exclusive Post-Market Surveillance (PMS) and Clinical Evidence workshop is just around the corner, happening at the beginning of December. Join us to gain practical insights from notified bodies, regulatory authorities, and industry experts. Don’t miss the opportunity to tackle PMS challenges and get your questions answered during the Q&A sessions. Register now: https://bit.ly/3XTY7tq. #DIALearning #TrainingCourse #MedicalDevices #CombinationProducts #PMS